Patents by Inventor Robert Roscigno

Robert Roscigno has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of treprostinil to treat and prevent ischemic lesions
    Publication number: 20050165111
    Abstract: The present invention describes novel methods for using Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof, for the treatment and/or prevention of ischemic lesions, such as digital ulcers, in subjects with scleroderma (including systemic sclerosis), Buerger's disease, Raynaud's disease, Raynaud's phenomenon and/or other conditions that cause such lesions. The invention also relates to kits for treatment and/or prevention of ischemic lesions, comprising an effective amount of Treprostinil or its derivative, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 16, 2004
    Publication date: July 28, 2005
    Inventors: Michael Wade, Roger Jeffs, Robert Roscigno, Deborah Strootman, Kathryn Bronstein
  • Use of 9-Deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylen e)-13,14-dihydro-prostaglandin f.sub.1 to treat peripheral vascular disease
    Patent number: 6054486
    Abstract: An improved treatment for peripheral vascular disease is described using 9-deoxy-2',9-.alpha.-methano-3-oxa-4,5,6-trinor-3,7-(1',3'-interphenylene) -13,14-dihydro-prostaglandin F.sub.1.
    Type: Grant
    Filed: November 13, 1998
    Date of Patent: April 25, 2000
    Assignee: United Technology Corporation
    Inventors: James W. Crow, Shelmer D. Blackburn, Jr., Robert Roscigno, Michael Wade, Gilles Cloutier, Martine Rothblatt